Inspire Investing’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-6,834
Closed -$503K 782
2022
Q1
$503K Sell
6,834
-306
-4% -$27.3K 0.06% 227
2021
Q4
$1.02M Sell
7,140
-650
-8% -$112K 0.12% 162
2021
Q3
$1.61M Buy
+7,790
New +$1.72M 0.2% 126
2021
Q2
Sell
-2,948
Closed -$535K 608
2021
Q1
$535K Sell
2,948
-796
-21% -$159K 0.08% 268
2020
Q4
$417K Buy
+3,744
New +$398K 0.09% 249

Other funds holding NVAX

Inspire Investing's NVAX Position: Q2 2022 in Review

Inspire Investing sold out of Novavax (NVAX) in Q2 2022, closing a stake of 6,834 shares — an estimated $503K sold.

Inspire Investing first reported a position in NVAX in Q4 2020 and held it in 5 quarters. The position peaked at $1.61M in Q3 2021. 325 funds tracked by Wall St. Rank hold NVAX as of Q2 2022.

  • Inspire Investing reported no remaining Novavax position as of Q2 2022 after selling out during the quarter.
  • Inspire Investing sold 6,834 Novavax shares in Q2 2022, an estimated $503K.
  • Inspire Investing first reported a position in Novavax in Q4 2020 and held it in 5 quarters.
  • Inspire Investing's Novavax position peaked at $1.61M in Q3 2021.
  • 325 funds tracked by Wall St. Rank held Novavax as of Q2 2022.

Based on Inspire Investing's 13F filing for Q2 2022, filed 10 Aug 2022.